Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
334
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

New phytoconstituents, anti-microbial and cytotoxic activities of Acacia etbaica Schweinf

, , &
Pages 5571-5580 | Received 28 Mar 2020, Accepted 03 Jul 2020, Published online: 23 Jul 2020
 

Abstract

Acacia etbaica is wild plant growing in the desert of Egypt, and it has folkloric medicinal uses. Phytochemical investigation of Acacia etbaica extracts led to the isolation and identification of seven compounds. Among these compounds are three new simple phenolics: Resacetophenone-6-methyl [1], Resorcinol [2], Resorcinol-O- β -Glucoside [3]; phenolic ester; and other four known compounds: Methylparaben [4]; two chromones, Noreugenin [5], Eugenin [6]; and one cyclitol: pinitol [7]. Compounds [1–3] isolated and identified for the first time from natural origin. In contrast, compounds [4–6] isolated for the first time from the family Fabaceae. The biological investigation was conducted on plant extracts and showed that the methylene chloride extract had a strong efficacy against Bacillus subtilis and good activity against Candida albicans. In contrast, the n-butanol extract showed extreme cytotoxic activity against Mammary gland breast cancer (MCF-7), and strong activity against Hepatocellular carcinoma (HEPG-2), and Colorectal carcinoma (HCT-116) cell lines.

Graphical Abstract

Acknowledgments

We would like to express my deepest gratitude to Nuclear Magnetic resonance Unit, Faculty of Pharmacy, Mansoura University for sample analysis, NMR support, and cooperation.

Authors’ contributions

Hazem A. Kadry and Ezzat A. M. Genady, researched literature and conceived the study. EL- Sayed. M. El-ghaly and Akram M. Kayed, was involved in protocol development, experimental studies, and data analysis. EL- Sayed. M. El-ghaly, Ezzat A. M. Genady, Hazem A. Kadry and Akram M. Kayed, wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.